Centene Raises 2026 Outlook on 2Q Profit, Revenue Growth

Dow Jones
07/28
 
 

Centene lifted its guidance for the year after revenue and profit growth in the second quarter were driven by strength in its core government-sponsored and individual healthcare lines.

The care and health insurance company on Tuesday said it now expects higher revenue in the year, driven largely by premium tax revenue, as well as its Marketplace and Medicaid businesses.

As a result, it now expects total revenues to be $6 billion higher, with a new range of $193.5 billion to $197.5 billion. Analysts expect $191.16 billion, according to FactSet.

Premium and service revenues guidance range was also increased by $2 billion to a new range of $173 billion to $177 billion.

At the same time, the company said its guidance floor was lifted to greater than $3.11 and its adjusted diluted EPS guidance floor to more than $4.80.

For the second quarter, Centene posted a net income of $1.09 billion, or $2.19 a share, compared with a loss of $253 million, or 51 cents a share, in the same quarter a year ago.

On an adjusted basis, which excludes one-off costs and exceptional items, earnings came to $2.51 a share. According to FactSet, analysts were expecting $1.08 a share.

Total revenues rose to $53.58 billion from $48.74 billion. Analysts expected a slight decline to $47.64 billion.

Premium and service revenues were $44.38 billion, compared with $42.47 billion, largely due to a 5% increase in Medicaid revenue, its largest contributor, and a 17% increase in Medicare.

Health benefits ratio, a key insurance metric showing the percentage of premium revenue spent on paying medical claims, came to 89.6%, down from 93% a year earlier. A lower ratio is better for profits. FactSet was expecting 91%.

 
 

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10